Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155800 · ClinicalTrials.gov registry record
A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury
A clinical trial, sponsored by Sense Diagnostics.
- Completed
- Registry status
- 75
- Enrollment target
NCT05155800 is a clinical trial that has completed, run by Sense Diagnostics. The registered enrollment target is 75 participants.
The verdict
NCT05155800 has completed, sponsored by Sense Diagnostics.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects between the ages of 22 to 50 will be enrolled. All TBI patients must have a diagnostic head CT scan within 24 hours of the injury. TBI patients without intracranial bleeding based on the CT scan must have a Glasgow Coma Scale (GCS) score at enrollment of ≤ 14. Total maximum duration of active monitoring with the device in this study is 48 hours with a clinical follow-up at day 7 after enrollment.
Interventions
- DEVICE SDx3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-12-28 |
| Est. Completion | 2023-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05155800
The ClinicalTrials.gov registry entry for NCT05155800 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sense Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SDx3 is the first listed.
NCT05155800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05155800 about?
NCT05155800 is a clinical study titled "A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury". The study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects between the ages of 22 to 50 will be enrolled. All TBI pati...
What is the current status of trial NCT05155800?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2021-12-28. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT05155800?
The interventions under investigation include: SDx3 (DEVICE).
Who is sponsoring clinical trial NCT05155800?
This trial is sponsored by Sense Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.